Keynote Speakers

Lotte Knudsen
Head of IDEA (Innovation & Data Experimentation Advancement) and Chief Scientific Advisor
Novo Nordisk

Colette Delawalla
Executive Director
Stand Up for Science

Victor Ambros
Professor, Program in Molecular Medicine; Silverman Professor of Natural Sciences
UMass Chan Medical School

Bob Coughlin
Managing Director – Life Science and Healthcare
JLL
Tide Talk Speakers
Tony Kulesa
Partner
Pillar VC
Beth Porter
Head of Studio Operations
C10 Labs
AJ Venkatakrishnan
Senior Vice President, A.I. Partnerships
nference
Michael Retchin
Founder
NewCo
Dan Spellman
Vice President of AI and OCI, Healthcare & Life Sciences
Oracle
Vinit Nijhawan
Managing Director
MassVentures
Chandra Ramanathan
VP & Head of External Innovation, Life Sciences
Danaher Corporation
Maggie o toole
Chief Executive Officer
LabCentral
Jo Viney
CEO, founder
Seismic Therapeutic
Jolyon Martin
Managing Director
White Pelican Innovation
Cristina M.
Director
RA Capital Management
Nolan Townsend
Chief Executive Officer
Lexeo Therapeutics
Sarah MacDonald
CEO
Life Science Cares
Aoife Brennan
President and CEO
LSC
Yvonne Hao
Secretary of Economic Development
Commonwealth of Massachusetts
Angelika Fretzen
Technology Translation Director & COO
Wyss Institute for Biologically Inspired Engineering
Jake Becraft
Co-Founder and CEO
Strand Therapeutics
Jennifer McNary
Co-Founder
Canary Advisors
Ann DeWitt
General Partner
Engine Ventures
Luba Greenwood
Chief Executive Officer, Gallop Oncology
Gallop Oncology
Stephen Linderman
Founder and CEO
Harvard Business School
Pita Navarro
Co-Founder, Chief Scientific Officer
Evvy
Liz Powell
Founder
Women’s Health Advocates, G2G
Elizabeth Bailey
Managing Partner
Foreground Capital
Michal Preminger
Head of Innovation, East North America
Johnson & Johnson
James Mutamba
Chief Business Officer
Arrakis Therapeutics
Kendra Rose
Senior Vice President
Bayer
Lori Badura
Vice President
Ipsen
Austin Draycott
Co-Founder
Cloverleaf Bio
Uli Stilz
Corporate Vice President, R&ED External Innovation Partners, External & Exploratory Innovation (E2I)
Novo Nordisk
Mary Clare McCorry
External Innovation Ecosystem and Scientific Engagement Lead
Sanofi
Catharine Smith
Executive Director
The Termeer Foundation
Mike Curtis
President and CEO
eGenesis, Inc.
Rohita Sharma, PhD.
Senior Director, Global Strategic Alliances – Patient Experience, Medical Affairs
Alexion Pharmaceuticals, Inc.
Eswar Iyer
Co-Founder and CEO, Head of Synthetic Biology
Aikium Inc.
Dominique Verhelle
Co-founder, President and CEO
NextRNA Therapeutics
Shinichiro Fuse
Partner/Managing Director
TPG
Lisa Huang
SVP, CSO Partner Team
Curie.Bio
Nirmesh Patel
Investor
Amino Collective
John Cumbers
Founder and CEO
Biological Enlightenment Studios
Pamela Silver
Professor of Systems Biology
Harvard Medical School
Ashley Beckwith
Board Member
Foray Bioscience
Ivan R. Jaubert
Director of Entrepreneurship & Strategic Partnerships
SynBioBeta
2025 Announced Content
2025 Summit Sponsors
Gold

Browne Consulting
Silver

SynBioBeta

Bakar Labs (QB3)

Collaborative Drug Discovery

TWIST

Plasmidsaurus

Germfree

Deep Origin
Travel Sponsors

Pliancy

Breakout Ventures

University of Texas at Dallas

University of Melbourne
Travel Sponsors

Science in Boston

Apply for
Activator
2024 COHORT
Nucleate's Activator forms pioneering biotech companies without taking equity.
Timeline and FAQ.
Deadline for US chapters is October 21st. Deadline for international chapters will vary. Please contact your local chapter to verify.
REQUIREMENTS
-
01Approval from PI
-
02Well defined technology / product backed by preliminary scientific research (Therapeutic modalities - Platform technologies - Diagnostics - Medical Devices)
-
03Existing IP to protect the technology, or clear path to file IP within the next year
-
04Clear potential to apply the technology
-
05Team intending and willing to 'spin-out' in the near future